Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Seeking Alpha / 3 Views

Acquisition strengthens Obagi Medical’s product portfolio with proven, scientifically backed, injectable portfolio

Comments